GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ASEP Medical Holdings Inc (OTCPK:SEPSF) » Definitions » YoY EBITDA Growth

ASEP Medical Holdings (ASEP Medical Holdings) YoY EBITDA Growth : 75.00% (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is ASEP Medical Holdings YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. ASEP Medical Holdings's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was 75.00%.

ASEP Medical Holdings's EBITDA per Share for the three months ended in Mar. 2024 was $-0.01.

ASEP Medical Holdings YoY EBITDA Growth Historical Data

The historical data trend for ASEP Medical Holdings's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ASEP Medical Holdings YoY EBITDA Growth Chart

ASEP Medical Holdings Annual Data
Trend Dec21 Dec22 Dec23
YoY EBITDA Growth
- -106.90 -61.67

ASEP Medical Holdings Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -41.18 -82.35 -36.36 -29.41 75.00

ASEP Medical Holdings YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

ASEP Medical Holdings's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(-0.097--0.06)/ | -0.06 |
=-61.67 %

ASEP Medical Holdings's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

YoY EBITDA Growth (Q: Mar. 2024 )
=(EBITDA per Share (Q: Mar. 2024 )-EBITDA per Share (Q: Mar. 2023 )) / | EBITDA per Share (Q: Mar. 2023 )) |
=(-0.006--0.024)/ | -0.024 |
=75.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ASEP Medical Holdings YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of ASEP Medical Holdings's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

ASEP Medical Holdings (ASEP Medical Holdings) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ASEP Medical Holdings Inc (OTCPK:SEPSF) » Definitions » YoY EBITDA Growth
Comparable Companies
XCNQ:MDMA XCNQ:PHRM XCNQ:COOL TSXV:QPT XCNQ:TELI TSX:AEZS XCNQ:BLAB NEOE:BMND TSXV:NRX TSXV:KNE OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
JJ8:Germany ASEP:Canada
Address
730 View Street, Suite 420, Victoria, BC, CAN, V8W 3Y7
Website
https://www.asepmedical.com
ASEP Medical Holdings Inc is a biotechnology firm pursuing the commercialization of broad-spectrum peptide technology. The Company is dedicated to addressing the global issue of antibiotic failure by developing novel solutions for significant unmet medical needs in human medicine and is engaged in the business of acquiring research and development assets, technology, or businesses in life sciences and medical diagnostics.